Original article by Misa Han
The Australian Financial Review – Page: 22 : 6-Mar-15

Shares in CSL are trading at $A92.18, and there is speculation that the stock will breach the $A100 level. Goldman Sachs is among the CSL bulls, with a share price target of $A107, although the average 12-month share price target of analysts polled by Bloomberg is just $A90.23. CSL shares rose above $A100 in September 2007, although the group then opted for a stock split. Wilson HTM Investment Group says it could do so again if the stock reaches $A100

CORPORATES
CSL LIMITED – ASX CSL, GOLDMAN SACHS AND PARTNERS AUSTRALIA PTY LTD, BLOOMBERG LP, WILSON HTM INVESTMENT GROUP LIMITED – ASX WIG, RIO TINTO LIMITED – ASX RIO, COMMONWEALTH BANK OF AUSTRALIA – ASX CBA, DEUTSCHE BANK AG, SONIC HEALTHCARE LIMITED – ASX SHL, RESMED INCORPORATED – ASX RMD, HEALTHSCOPE LIMITED – ASX HSO, ANSELL LIMITED – ASX ANN, NIB HOLDINGS LIMITED – ASX NHF, RAMSAY HEALTH CARE LIMITED – ASX RHC, COCHLEAR LIMITED – ASX COH, MEDIBANK PRIVATE LIMITED – ASX MPL, STANDARD AND POOR’S ASX 200 INDEX